Simulations Plus, Inc. (SLP) — Stock Score Summary

Simulations Plus, Inc. (SLP) has a MoatMap StockRank of 67/100 based on Quality (68/100), Value (36/100), and Momentum (47/100) factor scores. The current signal is BUY. Simulations Plus provides biosimulation software that helps pharma companies optimize drug development and reduce physical trial costs. As CDMO and clinical manufacturing costs rise, software that models drug behavior becomes highly valuable. However, its small scale ($338M) and high valuation limit immediate high-conviction deployment.

Simulations Plus, Inc. is a premier developer of biosimulation software and consulting services used in pharmaceutical research and drug development. The company's proprietary software, including GastroPlus, is widely adopted by global pharmaceutical firms and regulatory agencies like the FDA, creating high switching costs. It operates as a highly profitable, niche market leader in the computer-aided drug discovery sector.

Key Financial Metrics

Price$16.01
Market Cap$338M
P/E (Forward)18.07
Price/Book2.51
Return on Equity-38.8%
Return on Invested Capital5.2%
Debt/Equity0.38
Gross Margin62.0%
Operating Margin23.2%
Revenue Growth8.3%
Free Cash Flow$17M

Simulations Plus, Inc. operates in the Health Information Services industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Simulations Plus, Inc.’s (SLP) StockRank?
MoatMap’s StockRank for Simulations Plus, Inc. (SLP) is 67/100, with a Buy signal. It is a composite of Quality (68), Value (36), and Momentum (47) factor ranks across MoatMap’s 19,000+ stock universe.
Does Simulations Plus, Inc. have an economic moat?
Simulations Plus, Inc. (SLP) has a Quality factor score of 68/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Simulations Plus, Inc. a buy, hold, or sell?
MoatMap’s current signal for Simulations Plus, Inc. (SLP) is Buy, based on a StockRank of 67/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Simulations Plus, Inc. in?
Simulations Plus, Inc. (SLP) operates in the Healthcare sector, specifically the Health Information Services industry (United States).
Browse all ranked stocksSLP deep dive reportAI ChampionsHow we score stocksSense-check another stock